Are ocular complications of a high-dose glucocorticoid treatment appropriately monitored in patients with rheumatic diseases?

Author： Han Bobby   Yachoui Ralph   Yi Kayoung  

Publisher： Springer Publishing Company

ISSN： 0172-8172

Source： Rheumatology International, Vol.33, Iss.11, 2013-11, pp. : 2951-2952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of hypertension in patients with rheumatic diseases

By  

Blood Pressure, Vol. 22, Iss. 6, 2013-12 ,pp. : 399-400

Informa Healthcare

Access to resources Recommend Favorite

Ocular Vascular Involvement in the Rheumatic Diseases

By  

Current Rheumatology Reviews, Vol. 7, Iss. 1, 2011-02 ,pp. : 39-50

Bentham Science Publishers

Access to resources Recommend Favorite

Ocular Complications of Drugs Used in Rheumatic Disease

By  

Current Rheumatology Reviews, Vol. 7, Iss. 1, 2011-02 ,pp. : 61-68

Bentham Science Publishers

Access to resources Recommend Favorite

Effective High-Dose Clonazepam Treatment in Two Patients with Opsoclonus and Myoclonus: GABAergic Hypothesis

By  

European Neurology, Vol. 56, Iss. 4, 2006-12 ,pp. : 240-242

Karger

Access to resources Recommend Favorite

Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse

By  

European Neurology, Vol. 68, Iss. 1, 2012-06 ,pp. : 20-22

Karger

Access to resources Recommend Favorite